The mouse mammary tumor virus (MMTV) like sequences have been reported to be present in some human breast cancers, but their association with breast cancer development is still controversial.
Methods
In this retrospective study, we investigated the status of MMTV-like in 42 tumor biopsies and 18 paired normal tissues from Moroccan patients with breast cancer. MMTV-like env sequences were identified by PCR and confirmed by direct DNA sequencing.
Results
Specific MMTV-like env sequences were found in 24 (57.14%) cases of breast carcinomas, and 6 (33.3%) cases of matched normal breast tissues. Comparison to sociologic and clinicopathological parameters showed no significant association between the presence of MMTV-like sequences and age, menopausal status, histological subtype, histological grade, tumor size and the expression of hormone receptors (estrogen ER and/or progesterone PgR) and Her 2. However, a significant correlation was found between MMTV-like presence and parity (p = 0.024).
Conclusions
This present study confirms the presence of MMTV-like env sequences in breast cancer in Moroccan women, prompting further evaluation, on large sampling, to elucidate the probable causal roles of MMTV-like in breast cancer development.
The online version of this article (doi:10.1186/1750-9378-9-37) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SM collected paraffin blocs, analyzed clinical data, performed molecular analyzes and sequence alignment and wrote the manuscript; MEM co-supervised molecular analysis, contributed revising and critical drafting of the manuscript; RR conducted statistical analysis and drafted the manuscript; ZQ contributed to the molecular analysis and sequence alignment; MAtt co-supervised molecular analysis and drafted manuscript; MAmr conceived and coordinated the study, conducted histopathological analysis and drafted the manuscript. All authors have approved the final manuscript for publication.
Abkürzungen
BC
Breast cancer
MMTV
Mouse mammary tumor virus
ASR
Age-standardized incidence rate
HMTV
Human mammary tumor virus
PCR
Polymerase chain reaction
IBC
Inflammatory breast cancer
NIBC
Non inflammatory breast cancer
ILC
Invasive LobularCarcinoma
IDC
Invasive DuctalCarcinoma
PgR
Progesterone receptor
ER
Estrogen receptor
Her2
Human epidermal growth factor receptor 2.
Background
Worldwide, breast cancer is the leading cancer in women with approximately1.38 million new cases per year and 458.000 deaths annually [1]. In Morocco, breast cancer is the most predominant cancer and represents a great public health problem, with an age-standardized incidence rate (ASR) of 49.2 per 100 000 women [2].
Nowadays, multiple factors are associated with an increased risk of breast cancer, including age, gender, ethnicity, past history of breast cancer, reproductive and hormonal factors, family history and genetic factors, exposure to ionizing radiation, and environmental and lifestyle factors [3]. A high estrogen level is suspected to increase breast cancer risk, and other hormones such as progesterone, androgen derived from the ovaries and adrenal, thyroid hormones and insulin may play important roles in breast cancer development [3]. However, it’s widely accepted that hereditary transmission of some predisposition genes, especially BRCA1 and BRCA2, are the most known factors to be directly involved in the pathogenesis of breast cancer and is associated with 5–10% of breast cancer cases [4].
Anzeige
Since the discovery of the role of mouse mammary tumor virus (MMTV) as the causal agent of mammary tumor in mice [5], the viral etiology of human breast cancer has gained a growing interest. DNA sequences showing homology to those of MMTV virus have been detected in human breast cancer, suggesting that this virus called MMTV-like, also called Human Mammary Tumor Virus (HMTV), could be the human form of the MMTV and may be involved in the development of human breast cancer [6‐9].
More recently, several studies have demonstrated the presence of MMTV-like env sequences in 30 – 40% of breast cancer cases in several Western countries including the United States, Italy, Brazil and Argentina [10]. Overall, the prevalence of MMTV-like ranges between 78% in Australia to 0% in Iran, Mexico, Germany and Japan [11‐15].
Thus, the present study is the first one to be undertaken to determine the presence of MMTV-like in a set of Moroccan breast cancer samples and to evaluate the association between MMTV-like infection and some clinicopathological parameters. The aim of this study is to evaluate the involvement of MMTV-like in the development of breast cancer.
Methods
Samples
In this retrospective study, 42 formalin fixed paraffin embedded samples were collected at the pathology department of the National Institute of Oncology in Rabat from patients with breast cancer. To evaluate the presence of MMTV-like in non cancerous tissues, paired normal tissues from 18 patients were also analyzed. For these cases, sampling was done at least 2 cm away from the tumor. No consent was needed for this retrospective study. The study protocol was approved by the Ethical Committees of the Faculty of Medicine and Pharmacy of Rabat.
Anzeige
Clinicopathological parameters
All the data were retrieved from patients’ medical files, including age, parity, menopausal status, histological type and grade, tumor size, hormonal status and Her2 assessment.
Hormonal receptors (ER, PgR) were considered positive when ER and /or PgR were positive. The positive cut off is nuclear staining in at least 10% of tumor cells with any intensity.
DNA extraction
Sections of paraffin blocks were treated first with xylene to dissolve the paraffin and with ethanol to remove the remaining xylene. Cells were then lysed in the digestion buffer (Tris–HCl pH 8.0 10 mM, EDTA 10 mM, NaCl150 mM and SDS 2%) containing proteinase K (0.1 mg/ml). DNA isolation was performed with phenol-chloroforme extraction and ethanol precipitation. DNA was then resuspended in sterile distilled water [16]. The tissue DNA was precipitated with 2/5 volumes of 7.4 M ammonium acetate and 2 volumes of 100% ethanol, followed by incubation at -20°C and centrifugation at top speed (13000 relative centrifugal force). DNA was then resuspended in 25–30 μL of sterile distilled water and stored at -20°C until use. In order to evaluate the efficiency of DNA extraction, all samples were amplified by Polymerase Chain Reaction (PCR) using PC04 and GH20 primers specific for human β-globin gene (Table 1).
Table 1
List of primers used for PCR amplification and DNA sequencing
Primer
Fragment generated size
Sequence
Tm (°C)
β-globin
PC04
268 bp
5′-CAACTTCATCCACGTTCACC-3′
54.5
GH20
5′-GAAGAGCCAAGGACAGGTAC-3′
MMTV-like detection
489 F*
171 bp
5′-ACCAGGGGGTGAGTTTTTCT-3′
57
659R*
5′-CCCATCCTGCYTCATACCAT-3′
*F: Forward primer; *R: Reverse primer.
Detection of MMTV-like sequences by PCR
MMTV-like detection was performed by PCR using MMTV659R/MMTV489F primers (Table 1). These primers amplify a fragment of 171 bp of MMTV-like highly conserved in the env gene encoding the viral coat protein.
Amplification reaction was performed in a total volume of 25 μl. The amplification mixture contained 0.4 μM of each primer, 200 μM of each dNTP (dATP, dCTP, dGTP and dUTP), 0.5 units Taq DNA polymerase (Promega, France) and 3 μl of DNA sample in 1× Taq polymerase buffer. For every reaction, a negative control in which DNA template was omitted from the amplification mixture, and a positive control (MMTV DNA) were included. The thermal cycler (Gene Amp, PCR system 9700, Applied Biosystem, Foster city, CA) was programmed for 40 cycles with an initial denaturation at 94°C for 4 min. Each cycle was performed with a denaturation at 94°C for 30 sec, annealing at 57°C for 1 min and extension at 72°C for 1 min 30 sec. At the end of the last cycle, the mixtures were incubated at 72°C for 10 min.
The amplified products were submitted to electrophoresis on a 2% agarose gel in 1× Tris-borate-EDTA buffer at pH of 8.6. The gel was stained with ethidium bromide of 10 mg/ml 2 μL in 100 mL of 1× Tris-borate-EDTA, and the 171-bp amplified bands were visualized on an ultraviolet transilluminator to check for DNA amplification.
DNA sequencing
For each PCR product, both strands were sequenced, in independent reactions, using MMTV659R/MMTV489F primers. Firstly, the PCR products were purified by the ExoSaP-IT clean up system (USB, USA).Direct sequencing was performed on an ABI 3130XL DNA analyzer (Applied Biosystems, Foster city, CA, USA), using the sequencing primer and BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster city, CA, USA), according to manufacturer’s protocol. Nucleotides sequences were aligned and compared to the reference sequence of MMTV-like (Accession number: AF243039) and MMTV (Accession number: AY152721).
Statistical analysis
Categorical variables were expressed as numbers and percentages, and continuous variables were expressed as means ± SD or median (interquartile range). Data were analyzed using the statistical soft-ware SPSS version 13.0.
Anzeige
The results were compared using the Chi2 test to identify associations between the different collected parameters and MMTV-like status. The statistical relationship was considered as significant if the derived p value was < 0.05.
Results and discussion
Results
The mean age of patients was 41.6 [36.00 – 49.25] years, with extreme ages at 27 and 73. Among the 42 recruited patients, 29 were diagnosed having Inflammatory Breast Cancer (IBC) (69%) while the remaining 13 cases were Non Inflammatory Breast Cancer (NIBC) (31%). Interestingly, more than 78% of the patients were premenopausal and 31.71% were nulliparous.
The pathological results of the 42 breast cancer cases are reported in Table 2. Except for one patient who had Invasive Lobular Carcinoma (ILC), all the patients (97.62%) were diagnosed with Invasive Ductal Carcinoma (IDC).
Table 2
Pathological Characteristics of the 42 breast cancer cases
Characteristics
Number of cases (%)
Menopausal status
Pre-menopausal
33 (78.57)
Post-menopausal
9 (21.43)
Histological type
Invasive ductal carcinoma
41 (97.62)
Invasive lobular carcinoma
1 ( 2.38)
Histological grade
I
3 ( 7.14)
II
18 (42.86)
III
21 (51.22)
Tumor size
≤20 mm
3 ( 7.14)
20-50 mm
18 (41.86)
>50 mm
21 (51.22)
Histopathologicalgrade II and III were the most frequent with a large tumor size in half of the cases (Table 2).
Anzeige
Immunohistochemistry analysis showed that hormone receptors were positive in 78.57%. The human epidermal growth factor receptor 2 (Her2) status was positive in 28.57% of the cases (Table 3).
Table 3
Hormone receptors and Her2 results of the 42 breast cancer cases
Marker
Number of cases (Percentage)
ER
Positive
19 (45.24)
Negative
23 (54.76)
PgR
Positive
32 (76.19)
Negative
10 (23.81)
Her2
Positive
12 (28.57)
Negative
30 (71.43)
The presence of amplifiable DNA was confirmed for all 42 cases by PCR based-technique using primers for a fragment of β-globin gene and therefore all DNA samples were adequate for further analysis. Molecular detection of MMTV-like DNA, using PCR amplification of a conserved region of the viral env gene DNA, revealed the presence of viral DNA in 57.14% of breast cancer cases (24 of 42).
MMTV-like detection was also performed on 18 normal tissues anatomically related to tumor tissues, from patients with breast cancer. Results showed that 33.3% of cases are MMTV-like positive (6/18). Among them, 3 cases have MMTV-like env sequences in both normal and tumoral tissues whereas 3 cases have shown the absence of viral sequences in tumoral tissues.
The comparison of the clinicopathological and immunohistochemical data between the MMTV-like positive and MMTV-like negative breast cancer cases is summarized in Table 4. Overall, no association was found between the presence of MMTV-like sequences and age, menopausal status, the histological type, the SBR grade and the tumor size. Moreover, immunohistochemical expression of hormone receptors and Her2 did not vary significantly between MMTV-like positive and MMTV-like negative samples. However, our results clearly showed asignificant correlation between the presence of MMTV-like sequences and parity (P = 0,024).
Table 4
Correlation of MMTV-like status according to the clinicopathological parameters of breast cancer cases
Variables
N
Positive MMTV-like samples (%)
Negative MMTV-like samples (%)
P-value
Age
<35 years
8
2 (25)
6 (75)
0,093
35-50 years
26
16 (61.5)
10(38.5)
>50 years
8
6 (75)
2 (25)
Nulliparity
Yes
13
4 (30.8)
9 (69.2)
0,024
No
29
20 (69)
9 (31)
Menopausal status
Pre-menopausal
35
19 (54.3)
16 (45.7)
0,344
Post-menopausal
7
5 (71.4)
2 (28.6)
Inflammatory breast cancer
Yes
29
19 (65.5)
10 (34.5)
0,097
No
13
5 (38.5)
8 (61.5)
SBR grade
I
2
1 (50.0)
1 (50)
0,762
II
23
12 (52.2)
11 (47.8)
III
17
11 (64.7)
6 (35.3)
Tumor size
≤20 mm
3
3 (100)
0 (0)
0,348
20-50 mm
18
9 (50)
9 (50)
>50 mm
21
12 (57)
9 (43)
ER
+
19
9 (47.4)
10 (52.6)
0,349
-
23
15 (65.2)
8 (34.8)
PgR
+
32
20 (62.5)
12 (37.5)
0,281
-
10
4 (40)
6 (60)
Her2
+
12
7 (58.3)
5(41.7)
0,600
-
30
17 (56.7)
13(43.3)
Anzeige
All samples identified as positive for MMTV-like env sequence were sequenced in order to confirm the presence of MMTV-like in breast cancer samples. The complete PCR products’ sequences, aligned to MMTV and MMTV-like sequences are reported in Figure 1. Multiple nucleotide alignment showed 95-99% homology to MMTV and MMTV-like env sequences.
Figure 1
Multiple nucleotide alignment of the MMTV-likeenvsequences of 24 human breast carcinomas with the MMTV C3H (GenBank: AF228552.1) and MMTV-like SAG pseudogene (GenBank AF243039.1) reference sequences.
×
Overall, 8 point mutations and 1 deletion were found when comparing obtained sequences to the MMTV-like reference sequence. Interestingly, the point mutation G6241A is present in all analysed samples. Moreover, 10 of 24 cases have a nucleotide A at position 623, as the MMTV-like sequence, whereas the remaining 14 cases had a G, as the MMTV sequence.
Discussion
Worldwide, the viral etiology of breast cancer is largely discussed and remains controversial. During lasts decades, there is a resurgence of interest in a potential role of MMTV-like, a retrovirus homologue of MMTV involved in breast cancer in mice [17].
Many studies have reported that sequences highly homologous to MMTV were found in up of 40% of human breast cancers [18]. To our knowledge, this study is the first one conducted in Morocco to assess the involvement of MMTV-like in the development of breast cancer.
In our current study, the viral sequences were detected in 57.14% of cases. Additionally, the MMTV-like env sequences detected in our cases were highly homologous to the MMTV and the MMTV-like sequences reported previously [19, 20]. MMTV-like detection in African countries is limited to the Tunisian population as reported by Levine et al. [21] and Hachana et al. [22]. The breast cancer samples analysed by Levine et al. [21] were characterized by the predominance of the inflammatory form and showed a high frequency of MMTV-like (74%). However, in the study of Hachana et al. [22], inflammatory breast carcinoma was found only in 1.6% of cases (2/122), and only 14% of cases were MMTV-like positives. This difference suggested a correlation between MMTV-like and inflammatory breast cancer. In our study, MMTV-like was found in both inflammatory and non inflammatory breast cancer cases.
The association of MMTV-like and the inflammatory form of breast cancer was developed in a study of inflammatory breast cancer in the United States evaluating biospecimens obtained from patients enrolled in the North American inflammatory breast cancer registry. Reported data clearly showed that 71% of inflammatory breast cases were MMTV-like positives, as compared with 40% of non-inflammatory breast cancer cases (P < .0001) [23].
In addition, there were major geographic differences. In low incidence countries of breast cancer, MMTV-like env sequences were detected in less than 17% of cases. Indeed, studies of breast cancer cases from Japan and China have detected MMTV-like env sequences respectively in 12% [24] and 16.8% of tumors [25].In contrast, our result concords with the other studies performed in high-incidence countries of breast cancer, such as the United States where MMTV-like sequences were identified in 40–70% of breast cancer cases [23]. Similarly, studies of breast cancer cases from Argentina have detected MMTV-like sequences in 31.7% of the tumors [26, 27]. Interestingly, Mazzanti et al. have reported the presence of MMTV-like env sequence in 82% of ductal carcinoma in situ, but only in 35% of infiltrating ductal carcinoma [28]. In Australia, many studies have been conducted and showed a large discrepancy. Ford et al. [9] have reported MMTV-like sequences in 40% of breast cancer cases, but more recently a study conducted by Glenn et al. [29] revealed the presence of MMTV-like in 78% of the cases which is the highest frequency published up to now.
On the other hand, other studies conducted in England, Iran, Germany and Mexico, have never found the MMTV-like sequences in their breast cancer samples [30, 12‐14].
The observed differences could be explained by the technique used in the detection of the MMTV-like sequences; the quality of DNA obtained from breast cancer biopsies and could also be related to the prevalence of Musdomesticus in these regions. In fact, it’s widely accepted that mice might act as a reservoir and transmit the virus to humans [17]. Moreover, human breast cancer is higher in geographic areas (e.g., Western Europe, USA) where Mus domesticus is the most prevalent mouse species than other regions (e.g., Asia) and that M. domesticus mice produce more MMTV as they carry more exogenous virus and have more endogenous proviral loci than M. musculus[17].
In this study, MMTV-like sequences were found in 33.3% of normal tissues sampled at least 2 cm away from the tumor. Many studies have investigated the presence of MMTV DNA in normal tissues and showed the presence of MMTV-like env sequences in 0-19% [9, 22, 28]. The presence of viral DNA in normal tissues was largely discussed and all converge to the exogenous origin of the virus infection [17].Moreover, the high frequency of MMTV-like env sequences in our cases could be due to the sensitivity of the technique of detection. Indeed, the nested PCR used in our study, which is more sensitive than PCR, is often needed to detect the presence of virus DNA, because of low-level infections in humans, in contrast to mice [17].
Interestingly, MMTV-like env sequences were detected in normal tissues from 3 patients with breast cancer and not in the paired tumoral tissues. For these cases, breast cancer could have another origin and patients were on-infected by the virus. Therefore, it will be interesting to follow-up closely these patients to evaluate the outcome of the disease in the presence of the virus.
In the present study, the analysis of clinicopathological parameters showed no significant correlation between the presence of MMTV-like sequences and histological subtype, histological grade, tumor size, hormone receptors and Her 2 expression, suggesting that the infection by the MMTV-like is not associated with the tumor subgroups examined and the evolution of the disease. According to age, and even if it’s not statistically significant, the viral DNA is more frequent in elderly women leading to a trend association between viral infection and patients age, suggesting that MMTV-like may be a contributing factor in human breast carcinogenesis and breast cancer related MMTV-like requires more time for cancer development.
However, a significant association was found between MMTV-like positive samples and parity. This could be explained by the modification of breast tissues during pregnancy and breastfeeding. Indeed, the breast tissues are subject to continuous transformation. Thus, after pregnancy the breast tissue could be more susceptible to viral infection [31].
Conclusion
In conclusion, our study clearly shows the presence of MMTV-like env sequence in breast cancer cases in Morocco. This study prompts to conduct further evaluations, on large sampling, to elucidate the probable causal roles of MMTV-like in breast cancer development.
Acknowledgements
The authors would like to thank Dr. Hugo Arias-Pulido from The University of New Mexico for his contribution in the development of the experimental protocol and the donation of positive control of MMTV.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The authors declare that they have no competing interests.
Authors’ contributions
SM collected paraffin blocs, analyzed clinical data, performed molecular analyzes and sequence alignment and wrote the manuscript; MEM co-supervised molecular analysis, contributed revising and critical drafting of the manuscript; RR conducted statistical analysis and drafted the manuscript; ZQ contributed to the molecular analysis and sequence alignment; MAtt co-supervised molecular analysis and drafted manuscript; MAmr conceived and coordinated the study, conducted histopathological analysis and drafted the manuscript. All authors have approved the final manuscript for publication.
Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.
Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.
Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.
Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.
Update Onkologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
